Using an animal model for Alzheimer’s disease, it was also reported that AD-16 improved short-term and long-term memory, restored the IL-4 and IL-6 levels in the brain, and protected neurons (Zhou et al., 2016). This evidence concerns the gene IL6 and early-onset autosomal dominant Alzheimer disease.